3,7-bis[(4-methoxybenzyl)sulfanyl]-11-methyl-10,11,12,13-tetrahydro[1]benzothieno[3,2-e]di[1,2,4]triazolo[4,3-a:4,3-c]pyrimidine
|
|
3,7-bis[(4-methoxybenzyl)sulfanyl]-11-methyl-10,11,12,13-tetrahydro[1]benzothieno[3,2-e]di[1,2,4]triazolo[4,3-a:4,3-c]pyrimidine Eigenschaften
- Dichte
- 1.49±0.1 g/cm3(Predicted)
- pka
- -1.08±0.40(Predicted)
Sicherheit
3,7-bis[(4-methoxybenzyl)sulfanyl]-11-methyl-10,11,12,13-tetrahydro[1]benzothieno[3,2-e]di[1,2,4]triazolo[4,3-a:4,3-c]pyrimidine Chemische Eigenschaften,Einsatz,Produktion Methoden
3,7-bis[(4-methoxybenzyl)sulfanyl]-11-methyl-10,11,12,13-tetrahydro[1]benzothieno[3,2-e]di[1,2,4]triazolo[4,3-a:4,3-c]pyrimidine Upstream-Materialien And Downstream Produkte
Upstream-Materialien
Downstream Produkte
3,7-bis[(4-methoxybenzyl)sulfanyl]-11-methyl-10,11,12,13-tetrahydro[1]benzothieno[3,2-e]di[1,2,4]triazolo[4,3-a:4,3-c]pyrimidine Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.
Global( 2)Lieferanten
Firmenname | Telefon | Land | Produktkatalog | Edge Rate | |
---|---|---|---|---|---|
PHARMEKS Ltd. | -- |
sales@pharmeks.com | Finland | 6349 | 50 |
Specs | -- |
info@specs.net | The Netherlands | 6833 | 70 |
- 3,7-bis[(4-methoxybenzyl)sulfanyl]-11-methyl-10,11,12,13-tetrahydro[1]benzothieno[3,2-e]di[1,2,4]triazolo[4,3-a:4,3-c]pyrimidine
- [1]Benzothieno[3,2-e]bis[1,2,4]triazolo[4,3-a:4',3'-c]pyrimidine, 10,11,12,13-tetrahydro-3,7-bis[[(4-methoxyphenyl)methyl]thio]-11-methyl-
- 395679-36-4
- C29H28N6O2S3